Statistics
Publications
2
Citations
29
H-Index
2
Active since
2022
Affiliations
Kehui Zhou is an author at Yangzhou Vocational University specializing in olaparib therapy, gemcitabine-based therapy, and dna damage signaling.
Publications per year
2022–2023
2
2
Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells
Yang Zhao, Kehui Zhou, Xiangyu Xia et al. · Cell Cycle · 2022 · 12 citations · Full text
1–2 of 2